Abstract-ATP is an essential energy substrate for cellular metabolism, but it can also influence many biological processes when released into the extracellular milieu. Research has established that extracellular ATP acts as an autocrine/ paracrine factor that regulates many physiological functions. Alternatively, excessive extracellular ATP levels contribute to pathophysiological processes, such as inflammation, cell proliferation and apoptosis, and atherosclerosis. Renal P2 receptors are widely distributed throughout glomeruli, vasculature, and tubular segments and participate in controlling renal vascular resistance, mediating renal autoregulation, and regulating tubular transport function. This review will focus on the role of ATP-P2 receptor signaling in regulating renal microvascular function and autoregulation, recent advances on the role of ATP-P2 signaling in hypertension-associated renal vascular injury, and emerging new directions. (Hypertension. 2011;58:00-00.) S ince ATP's discovery as a coneurotransmitter nearly 40 years ago, 1 ATP is no longer regarded as just an intracellular energy source. Extracellular ATP is an autocrine/ paracrine factor that regulates many physiological functions, including neuronal signaling, control of vascular tone and reactivity, mechanosensation, and ion transport. Alternatively, excessive extracellular ATP levels contribute to pathophysiological processes, such as inflammation, cell proliferation and apoptosis, and atherosclerosis. 2 Extracellular ATP exerts its effects by activating distinct P2 purinoceptors, P2X and P2Y (Figure 1 ). P2X receptors are ligand-gated ion channels and exist as homotrimers (P2X 1 to P2X 7 ), meaning that 3 of the same subunit type associate to form a functional channel. They can also associate as multimeric complexes involving different types of P2X receptor subunits to form functional channels (P2X 1/2 , P2X 1/5 , P2X 2/3 , P2X 2/6 , P2X 4/6 , and P2X 1/4 ). P2X 1 and P2X 3 receptors display unique responses to ATP. Both receptors and their heteromers desensitize rapidly, although the mechanism responsible for desensitization is not clear. In contrast, P2Y receptors are G protein-coupled receptors including 8 members (P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , and P2Y 14 ). UTP is a potent agonist for P2Y 2 , P2Y 4 , and P2Y 6 receptors.
S ince ATP's discovery as a coneurotransmitter nearly 40 years ago, 1 ATP is no longer regarded as just an intracellular energy source. Extracellular ATP is an autocrine/ paracrine factor that regulates many physiological functions, including neuronal signaling, control of vascular tone and reactivity, mechanosensation, and ion transport. Alternatively, excessive extracellular ATP levels contribute to pathophysiological processes, such as inflammation, cell proliferation and apoptosis, and atherosclerosis. 2 Extracellular ATP exerts its effects by activating distinct P2 purinoceptors, P2X and P2Y (Figure 1 ). P2X receptors are ligand-gated ion channels and exist as homotrimers (P2X 1 to P2X 7 ) , meaning that 3 of the same subunit type associate to form a functional channel. They can also associate as multimeric complexes involving different types of P2X receptor subunits to form functional channels (P2X 1/2 , P2X 1/5 , P2X 2/3 , P2X 2/6 , P2X 4/6 , and P2X 1/4 ). P2X 1 and P2X 3 receptors display unique responses to ATP. Both receptors and their heteromers desensitize rapidly, although the mechanism responsible for desensitization is not clear. In contrast, P2Y receptors are G protein-coupled receptors including 8 members (P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , and P2Y 14 ) . UTP is a potent agonist for P2Y 2 , P2Y 4 , and P2Y 6 receptors.
The importance of P2 receptors in regulating renal function has been clarified over the past 2 decades by the identification and characterization of P2 receptors throughout renal structures. [3] [4] [5] [6] Renal P2 receptors are widely distributed throughout glomeruli, vasculature and tubular segments, and participate in controlling renal vascular resistance, mediating renal autoregulation, and regulating tubular transport. Recent studies indicate that alteration of ATP-P2 receptor signaling occurs in hypertension. [7] [8] [9] [10] [11] In this review, we will integrate recent findings on ATP-P2 receptor signaling in renal microvascular function, autoregulation, and hypertensionassociated renal vascular injury with existing information, and emerging new directions will be discussed.
Expression of P2 Receptors in the Kidney
Renal P2 receptor expression has been explored extensively. The vasculature, glomerulus, and nearly every nephron segment express Ն1 P2 receptor subtype. Each tubular segment expresses different P2X and P2Y receptor subtypes at apical or basolateral membranes or both. P2Y 2 receptors expressed in the distal tubule/collecting duct are important for sodium and fluid reabsorption. Deletion of P2Y 2 receptors reportedly leads to salt-resistant hypertension, 12 and the P2Y 2 receptor gene is linked to essential hypertension. 13 More specific information on how P2 receptor subtypes influence tubular solute transport can be found in several excellent reviews. [3] [4] [5] 14 P2X 1, P2X 2 , and P2X 4 receptors are detected in preglomerular microvessels. 7, [15] [16] [17] [18] Western blot analysis and immunohistochemical staining reveal intense P2X 1 receptor expression in vascular smooth muscle cells of preglomerular microvessels, especially afferent arterioles, whereas efferent arterioles, glomeruli, and renal tubules show no detectable staining, suggesting that P2X 1 receptors are predominantly expressed by preglomerular microvessels. 7,16 -18 Recently, patch-clamp studies combined with mRNA analysis suggest that preglomerular vascular smooth muscle cells also express heteromeric P2X 1/4 receptors. 19 In addition, low level P2X 7 receptor expression was reported in glomeruli and preglomerular vessels, but expression levels reportedly increase dramatically under pathological conditions, such as diabetes mellitus, inflammation, and hypertension, 8 suggesting an important role for P2X 7 receptors in inflammatory processes. Afferent arterioles also express P2Y 1 and P2Y 2 receptors, whereas efferent arterioles express only P2Y 1 receptors. 16, 18 The varied distribution of P2 receptors in the kidney indicates that ATP-P2 signaling pathways play important roles in regulating renal vascular, glomerular, and tubular function.
ATP Release and Metabolism
ATP is released from sympathetic nerve fibers on stimulation, but it can also be released from nonexcitatory cells. 20 Evidence suggests that ATP is released from glomerular cells, 21 juxtaglomerular cells, 22 macula densa, 5 and proximal tubular epithelium. 23 In the normal kidney, the extracellular ATP concentration is estimated to be 1 nmol/L in glomeruli, 21 6 to 9 nmol/L in interstitial fluid, 9, 24 and 100 to 300 nmol/L in proximal and 33 nmol/L in distal tubular fluid 23 but may increase markedly under pathological conditions. 9, 11, 20 Extracellular ATP concentrations between 10 and 100 nmol/L vasoconstrict juxtamedullary afferent arterioles under in vitro conditions. 7, 10, 25, 26 It is important to note, however, that these concentrations reflect superfused ATP solutions that encounter competing currents, diffusion barriers, and unstirred water layers. Given that the ATP concentration in microdomains is probably important, it is difficult to directly translate interstitial fluid measurements with in vitro data. Extracellular ATP is rapidly catabolized in vivo by ectonucleotidases (Figure 1 ), classified as ectonucleotide pyrophosphatase phosphodiesterases, ectonucleoside triphosphate diphosphohydrolases (NTPD), ecto-5Ј-nucleotidase, and alkaline phosphatase. Among them, NTPDase1, NTPDase2, NTPDase3, ectonucleotide pyrophosphatase phosphodiesterase 1, ectonucleotide pyrophosphatase phosphodiesterase 3, and ecto-5Ј-nucleotidase are expressed in rat or mouse kidneys with varying degrees of expression along the nephron, vasculature, and peritubular spaces. 27, 28 Although the functional significance of intrarenal ectonucleotidases is poorly understood, all of the components for synthesis and metabolism of ATP exist in the kidney. Therefore, the extracellular ATP concentration appears tightly controlled by ectonucleotidases.
ATP-P2 Receptor Signaling in Renal Hemodynamics
Normal kidney function is critical for maintenance of physiological blood volume, blood pressure, and normal cellular metabolism. Efficient renal function relies on a relatively constant renal blood flow (RBF), glomerular capillary pressure, and glomerular filtration rate. The kidney achieves these stable hemodynamic conditions primarily through precise adjustment of afferent arteriole resistance, which is influenced by numerous extrinsic and intrinsic factors, including NO, endothelium-derived hyperpolarizing factor(s), angiotensin II (Ang II), endothelin, and prostaglandins. These autocrine, paracrine, and endocrine factors directly or indirectly modulate afferent arteriolar resistance to achieve the stable hemodynamic conditions needed for efficient renal function. Loss, or reduction, of afferent arteriolar reactivity to vasoactive agents may contribute to renal injury in hypertension.
The likelihood that P2 receptors regulate renal hemodynamics and vascular reactivity is supported by in vivo and in vitro studies. Intravenous infusion of ATP or the P2X agonist ␤, ␥-methylene ATP caused a rapid transient reduction in RBF followed by an increase of RBF in anesthetized rabbits. 29 The increased RBF was significantly attenuated by the adenosine receptor antagonist, 8-(p-Sulfophenyl) theophylline, implicating A 2 receptors in the ATP-induced increase in RBF. In a subsequent study, infusion of the P2X agonist ␣, ␤-methylene ATP reduced RBF and cortical and medullary blood flow by 63%, 58%, and 49%, respectively, without changes in mean arterial pressure, 30 suggesting that the renal vasculature is more sensitive to P2 receptor stimulation than other vascular beds. We recently applied a more selective P2X 1 and P2X 3 receptor antagonist, P 1 ,P 5 -Di-inosine-5Ј-pentaphosphate pentasodium salt to assess the role of renal P2X 1 receptors in vivo. 31 Bolus intravenous infusion of ␣, ␤-methylene ATP dose-dependently decreased RBF. This response was prevented by P2 receptor blockade with pyridoxal-phosphate-6-azophenyl-2Ј, 4Ј-disulfonic acid (PPADS) or P 1 ,P 5 -Di-inosine-5Ј-pentaphosphate pentasodium salt, consistent with renal vascular expression of ␣, ␤-methylene ATP-sensitive P2X 1 and P2X 3 receptors. Notably, P2X 3 receptor expression has not been convincingly demonstrated for the preglomerular microvasculature, 17, 19 thereby implicating P2X 1 receptors in the response to ␣, ␤-methylene ATP and highlighting a specific role for P2X 1 receptors in regulating RBF. Others report that ATP evoked either vasoconstriction or vasodilation under different dietary salt conditions. For example, low-dose ATP infusion did not change total or cortical RBF but increased inner medullary blood flow in anesthetized rats fed a low-salt (0.15%) diet. The same dose decreased both inner and outer medullary blood flow in rats fed 4% salt. 32 The increase in inner medullary blood flow in low-salt rats was prevented by blockade of NO production, whereas the ATP-mediated medullary vasoconstriction with high-salt intake was prevented by inhibition of cytochrome P450 activity. 32 effects were eliminated by P2 receptor blockade with PPADS. 32 Therefore, renal vascular responses to ATP can vary under different "environmental" conditions, and these differences could reflect direct receptor-specific actions or vasoactive responses mediated, or modulated, by vasoactive substances, such as NO or cytochrome P450 products. The influence of ATP on renal hemodynamics has also been demonstrated using isolated perfused rat kidney preparations under different basal tone conditions (preconstricted versus nonpreconstricted). 33, 34 For example, under basal tone conditions, ATP and its agonists evoked marked vasoconstriction with the following rank order potency: 33 indicating greater sensitivity of the renal vasculature to P2X receptor stimulation than P2Y. In contrast, in preconstricted, isolated perfused rat kidneys, ATP, 2-methylthio ATP, and UTP caused vasodilation at low concentrations and vasoconstriction at higher concentrations. The vasodilation was blunted by N G -nitro-Larginine methyl ester, removal of endothelium, or by nonspecific blockade of K ϩ channels during exposure to high extracellular K ϩ (25 mmol/L). 33, 34 Collectively, these observations indicate that P2X receptor stimulation causes vasoconstriction, whereas activation of P2Y receptors causes vasoconstriction or tone-dependent vasodilation. The ability of N G -nitro-L-arginine methyl ester and removal of the endothelium to blunt ATP-mediated renal vasodilation argues that P2 receptors are expressed by endothelial cells and that these receptors couple through NO synthase. The observation that inhibition of K ϩ channel function also blunted P2Y agonist-mediated renal vasodilation loosely suggests that endothelium-derived hyperpolarizing factor(s) may also be involved, although this remains to be clarified.
P2 Receptor Action on Preglomerular and Postglomerular Microvessels
ATP's ability to regulate renal microvascular function has been established by determining segment-specific vascular responses to exogenously applied ATP or ATP analogues. 6, 24, 25, 35, 36 Administration of ATP and ␣, ␤-methylene ATP elicited concentration-dependent vasoconstriction of isolated-perfused rabbit afferent arterioles. 35 The addition of an A 1 receptor blocker abolished ATP-induced vasoconstriction in the proximal region of the arteriole, but a significant vasoconstriction still existed in the distal region of the arteriole, suggesting that ATP-induced vasoconstriction reflects activation of P2 receptors in distal arteriolar segments but partially via activation of A 1 receptors in more proximal arteriolar regions. Using blood-perfused rat juxtamedullary nephron afferent arterioles, superfusion of ATP; ␣, ␤-methylene ATP; or ␤, ␥-methylene ATP evokes biphasic afferent arteriolar vasoconstriction with a rapid initial vasoconstriction, followed by a stable plateau phase. 6, 24, 36 Sustained P2 receptor-mediated vasoconstriction was clearly manifested in afferent arterioles at low ATP concentrations, but upstream arcuate and interlobular arteries exhibited only transit vasoconstriction at ATP concentrations Ͻ100 mol/L. By contrast, ADP, AMP, or adenosine did not mimic the afferent arteriole vasoconstrictor profiles of ATP or ␣, ␤-methylene ATP. The magnitude of ATP-mediated vasoconstriction was enhanced during adenosine receptor blockade. 25 These findings suggest that ATP-mediated vasoconstriction involves P2 receptor activation rather than stimulation of A 1 receptors by ATP metabolites. Interestingly, ␣, ␤-methylene ATP-mediated vasoconstriction was blocked by P2X 1 receptor desensitization induced by pulsatile exposure to ␣, ␤-methylene ATP (5.0 mol/L for 60-second intervals). 26 Importantly, ATP evoked no detectable response from efferent arterioles with ATP concentrations as high as 100 mol/L. 6, 24, 36 Because afferent arterioles are the primary resistance vessels regulating renal vascular resistance and autoregulatory efficiency, the potent vasoconstrictor influence of ATP-P2X 1 receptor signaling in afferent arterioles implicates P2X 1 receptors in regulating glomerular hemodynamics.
Afferent arterioles also exhibit significant vasoconstrictor responses to P2Y receptor stimulation. 24, 36 Application of the P2Y receptor agonist, 2-methylthio-ATP, evoked concentration-dependent vasoconstriction of afferent arterioles. UTP or ATP-␥-S, more selective agonists for P2Y 2 receptors, elicited greater vasoconstrictions than 2-methylthio-ATP, providing functional evidence for P2Y 2 receptor expression by afferent arterioles. These studies establish ATP as a potent vasoconstrictor of afferent arterioles and suggest that renal microvascular function is regulated by activation of P2X and P2Y receptors.
Intracellular Signaling Pathway Used by P2X and P2Y Receptors
Generally, P2X and P2Y receptors signal through modulation of intracellular Ca 2ϩ , albeit by different mechanisms. [37] [38] [39] [40] [41] Studies using freshly isolated preglomerular microvascular smooth muscle cells 38, 40, 42 showed that ATP and UTP both produce biphasic increases in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) typified by a rapid peak response, followed by a more stable plateau phase. 40 40 In contrast, P2X receptor stimulation with ␣, ␤-methylene ATP elicited a more monophasic increase in [Ca 2ϩ ] i , which was eliminated by Ca 2ϩ -free medium, diltiazem, or a specific P2X 1 receptor antagonist, NF-279. 42 These observations are consistent with responses to ATP, UTP, or ␣, ␤-methylene ATP in afferent arterioles treated with diltiazem. 37, 38 Collectively, in preglomerular microvessels, vasoconstriction by P2X receptor activation is largely achieved by influx of extracellular Ca 2ϩ via activation of 41 In addition, the Rho-RhoA pathway is known to stimulate vasoconstriction by increasing Ca 2ϩ sensitivity. Inhibition of Rho-kinase activation not only attenuated ATP and ␣, ␤-methylene ATP-mediated afferent arteriolar vasoconstriction but also blunted pressure-mediated vasoconstriction, whereas UTP-mediated vasoconstriction remained intact. 45 These data implicate Rho-kinase activation in the ATP-P2X receptor signaling pathway associated with renal autoregulation.
Renal Autoregulation
Efficient renal function depends on stable RBF and glomerular filtration rate. Kidneys achieve these stable hemodynamic conditions in part through autoregulation of afferent arteriolar resistance. Accurate adjustment of afferent arteriolar resistance provides an essential buffer preventing transmission of high arterial pressure to the glomerulus. This protective property of afferent arterioles is achieved primarily by 2 distinct mechanisms, the intrinsic myogenic response and the tubuloglomerular feedback (TGF) mechanism. 6, 46 Recent studies propose a third component contributing to autoregulation, but the mechanism remains unclear. 47 The myogenic response is inherent to the preglomerular arteries and arterioles. The TGF response regulates vascular resistance in the terminal juxtaglomerular segment of the afferent arteriole in response to changes in NaCl concentration sensed by macula densa cells. Therefore, afferent arterioles are the principal resistance vessels determining renal autoregulatory efficiency. Lack of accurate resistance adjustments renders glomeruli susceptible to elevated glomerular capillary pressure in hypertension, reflected in glomerular injury and progression to renal failure. 48 
ATP-P2 Receptor Signaling in Renal Autoregulation
An important challenge facing renal physiologists is to understand the signaling mechanisms linking the distal tubular NaCl delivery and macula densa cells to autoregulatory function. Both ATP and its breakdown product, adenosine, are indicated as extracellular messenger molecules mediating aggregate autoregulatory behavior.
Evidence supporting extracellular ATP as a messenger molecule mediating autoregulatory behavior is derived from in vitro and in vivo work. An initial study in dogs showed that RBF autoregulation was significantly blunted during saturation of P2 receptors with continuous intra-arterial administration of ATP. 49 Afferent arteriolar autoregulatory behavior was inhibited by deliberate P2X 1 receptor desensitization, 26 nonselective P2 receptor blockade using suramin or PPADS, 36 and selective P2X 1 receptor blockade with NF-279. 50 RBF autoregulation was inhibited in vivo by P2 receptor blockade using either PPADS or the highly selective P2X 1 antagonist, P 1 ,P 5 -Di-inosine-5Ј-pentaphosphate pentasodium salt, yielding a passive pressure-flow relationship. 31 In contrast, the in vivo autoregulatory response was not significantly altered during A 1 receptor blockade with 8-cyclopentyl-1, 3-dipropylxanthine. Thus, an intact P2X 1 receptor system appears required for manifestation of normal autoregulatory behavior.
Studies in P2X 1 knockout mice provide valuable information supporting a role for ATP-P2X 1 receptor signaling in renal autoregulation. Afferent arterioles from P2X 1 -deficient mice displayed impaired pressure-mediated autoregulatory behavior. 50 Inhibition of TGF responses by papillectomy or furosemide failed to further modify the pressure-diameter relationship in P2X 1 knockout mice but not in wild-type control mice. Although TGF responses were not directly measured in these studies, the data suggested that the TGF response was blunted or absent in P2X 1 -deficient mice. Meanwhile, A 1 receptor-mediated vasoconstriction in P2X 1 -deficient mice was similar to their wild-type littermates. These data provide compelling evidence that impaired pressure-mediated arteriolar vasoconstriction is attributed to a lack of P2X 1 receptor activation in afferent arterioles rather than loss of A 1 signaling.
ATP-P2 Receptor Signaling in TGF
Renal interstitial ATP concentration correlates directly with manipulation of TGF activity, consistent with extracellular ATP as an autoregulatory signaling molecule. 24, 51 Microdialysis studies in anesthetized dogs showed that renal interstitial ATP concentrations correlated directly with renal arterial pressure between 130 and 75 mm Hg. The interstitial fluid ATP concentration averaged 6.5 nmol/L with renal perfusion at 130 mm Hg and decreased to 4.5 and 2.8 nmol/L during a stepwise perfusion pressure reduction to 105 and 80 mm Hg, respectively. Stimulation of TGF by distal tubular NaCl loading with acetazolamide increased the interstitial ATP concentration, which was accompanied by an increase in renal vascular resistance. The change in interstitial ATP concentration was not blocked by L-VDCC blockade, 51 indicating that ATP release occurs before vascular smooth muscle cell depolarization. The interstitial adenosine concentration remained unchanged despite changes in renal perfusion pressure. 24 These studies suggest that ATP is released in response to autoregulatory stimuli, and renal vascular resistance correlates directly with interstitial ATP concentrations but not adenosine concentrations.
Elegant in vitro studies by Bell et al 5 provide compelling evidence demonstrating ATP release from macula densa cells via a maxi anion channel in response to the TGF stimulation. 52 By monitoring [Ca 2ϩ ] i in biosensor cells overexpressing P2X receptors, they found that increasing the luminal NaCl concentration at the macula densa significantly increased [Ca 2ϩ ] i in the biosensor cell when it was placed adjacent to the macula densa's basolateral surface but not if placed adjacent to thick ascending limb cells. 5 This is the first direct evidence that ATP is released from the basolateral surface of macula densa in response to a TGF stimulus (Figure 2 ). These data support the idea that TGF signals begin with ATP release from macula densa cells; however, whether ATP released from the macula densa cells acts directly on P2 receptors of afferent arterioles or whether ATP is degraded by ectonucleotidases to adenosine leading to A 1 receptor-dependent TGF adjustments remains to be determined. 53 The studies from Bell et al 5 were extended by combining confocal imaging techniques and highly sensitive calcium fluorophores to directly link TGF activity, ATP release, and afferent arteriolar responses. 52 Peti-Peterdi 52 reported that activation of TGF signals triggered rapid propagation of a Ca 2ϩ wave from the macula densa toward the afferent arteriole and glomerulus, leading to significant arteriolar constriction within 10 seconds. Propagation of Ca 2ϩ signals and reduction of arteriolar diameter were eliminated by inhibiting P2 receptor activation with suramin or suffusing with ATP hydrolyzing enzymes (apyrase and hexokinase) but not by A 1 receptor blockade with 8-cyclopentyl-1, 3-dipropylxanthine. 52 These studies suggest that ATP released from the macula densa cells, rather than adenosine metabolized from ATP, plays an essential role in transmitting TGF signals to the afferent arterioles. Overall, these observations support the hypothesis that extracellular ATP is an important paracrine signaling molecule participating in TGF responses and regulating afferent arteriolar resistance, but they also underscore the need for more direct micropuncture studies.
Adenosine-P1 Receptor Signaling in TGF
ATP released from the macula densa could be rapidly degraded to adenosine by ectonucleotidases expressed in renal interstitial tissue and microvessels before P2 receptor activation. 27, 28 Adenosine is postulated to mediate TGFdependent vasoconstriction by activating A 1 receptors on afferent arterioles. 46, 53 In contrast to the study by Peti-Peterdi described in the previous paragraph, 52 micropuncture studies showed that TGF responses were blunted by A 1 receptor blockade or by inhibition of 5Ј-nucleotidase. 54 In in vitro studies, TGF-mediated afferent arteriolar vasoconstriction was enhanced by application of apyrase or hexokinase but abolished by inhibiting ecto-5Ј-nucleotidase or by blockade of A 1 . 55, 56 The TGF response remained intact in this in vitro preparation during inhibition of P2 receptors with suramin. 56 Recent studies using mice deficient in A 1 receptors ecto-5Ј-nucleotidase gene or NTPDase1 support adenosine as a TGF signaling molecule. 47, [57] [58] [59] [60] [61] TGF responses were either completely abolished or significantly attenuated. However, a recent report using in vivo micropuncture indicates that P2 receptor blockade using either PPADS or suramin did not significantly alter TGF responses in 2 different strains of mice. 62 Interestingly, as noted by the author, TGF responses tended to be numerically lower during P2 receptor blockade, although not significantly so. In a set of preliminary data published in a review article, TGF responses also tended to be smaller in P2X 1 receptor knockout mice. 63 Small decrements in TGF magnitude could be attributed to many technical, experimental, or nonphysiologic causes, but they could also represent some "low-level interaction" between significant influences of P1 receptor activation and smaller influences from P2 receptor activation in TGF-dependent resistance adjustments. Interested readers are referred to excellent reviews on this topic. 46, 53, 63 These results support adenosine as a mediator of TGF.
ATP-P2 Receptor Signaling in Hypertension
Hypertensive renal injury is a major risk factor associated with progressive cardiovascular disease. Although in past decades numerous studies have established that ATP contributes to many pathophysiological processes, including cell proliferation, necrosis, inflammation, and vascular remodeling, studies of ATP-P2 receptor signaling in hypertension are few. Knockout mice have been developed for several P2 receptor subtypes (P2X 1 , P2X 2 , P2X 3 , P2X 4 , and P2X 7 ) and some P2Y receptor subtypes. 2 Both P2X 1 and P2X 4 receptordeficient mice exhibit a small but significant increase in 65 Although the role of P2X 4 receptors in regulating the renal microvasculature is unknown, this study implies that altered ATP-P2 signaling can lead to vascular dysfunction. Furthermore, P2X 7 receptor expression is markedly increased in Ren-2 hypertensive rat kidneys. 8 Studies also showed a close link between blood pressure and a genetic variation in the region of the human P2X 7 gene. 66 These studies indicate that altered ATP-P2 receptor signaling might lead to vascular dysfunction and contribute to renal injury under hypertensive conditions. Although the role of ATP-P2 receptor signaling in the pathophysiology of hypertension remains unclear, the interstitial levels of ATP and gene expression of ectonucleotidases are reportedly increased in Ang II and N G -nitro-L-arginine methyl ester-induced hypertensive rats, respectively. 9, 11 Chronic Ang II infusion for 2 weeks increased renal interstitial ATP concentration from 5.6 to 11.8 nmol/L. 9 Simultaneous treatment with the P2 receptor antagonist PPADS or the P2Y 12 receptor antagonist clopidogrel attenuated afferent arteriolar hypertrophy and glomerular injury despite persistent hypertension. Our group has begun investigating the mechanisms involved in impaired renal microvascular function and autoregulation under hypertensive conditions. 7, 10 Studies using Ang II-infused hypertensive rats revealed that, apart from impaired afferent arteriolar autoregulation, these rats also exhibit impaired P2X 1 receptor reactivity. Afferent arterioles from Ang II-infused rats exhibit markedly attenuated vasoconstriction to ATP and ␤, ␥-methylene ATP when compared with vessels from normotensive rats. 7, 10 Interestingly, responses to P2Y 2 receptor activation and P1 receptor activation were unaffected. 7 Parallel loss of pressuremediated autoregulatory vasoconstriction and P2X 1 receptor signaling is consistent with the ATP-P2X 1 receptor system being important for autoregulatory reactivity. Taken together, these studies support the hypothesis that impaired ATP-P2 receptor signaling in hypertension could contribute to hypertensive renal injury through impaired autoregulatory control of glomerular perfusion pressure.
Growing evidence suggests that inflammatory factors play crucial roles in the development of cardiovascular disease and hypertensive renal injury. 67 Inflammatory factors, such as nuclear factor B and monocyte chemotactic protein 1, are increased in hypertensive animal models, and antiinflammatory treatment prevents progressive renal injury. 67, 68 Thus, inflammatory factors may contribute to hypertensioninduced renal injury by impairing afferent arteriolar reactivity and reducing autoregulatory capability in Ang II-infused hypertensive rats. Interestingly, treatment with the nonspecific anti-inflammatory agent pentosan polysulphate preserved normal afferent arteriolar autoregulatory behavior in Ang II-infused hypertensive rats despite sustained hypertension. 10 Simultaneously, afferent arteriolar responses to ATP and ␤, ␥-methylene ATP were also preserved. Treatment with pentosan polysulphate also corrected the elevated plasma transforming growth factor-␤1 concentration and ameliorated renal microvascular injury in Ang II-infused rats, suggesting that increased transforming growth factor-␤ may contribute to renal microvascular dysfunction in hypertension. This possibility is supported by previous observations that acute exposure to transforming growth factor-␤ diminished autoregulatory capability of afferent arterioles. 69 Normalization of autoregulatory behavior and microvascular reactivity to P2X 1 receptor activation by treatment with pentosan polysulphate supports an active role for ATP-P2X 1 signaling in autoregulation and suggests that inflammatory processes contribute to the decline in autoregulatory efficiency in hypertension. Collectively, these data suggest a potentially important mechanism whereby reduced P2X 1 -mediated vasoconstriction of afferent arterioles accounts for impairment of autoregulation and promotes progression to renal injury.
The mechanisms underlying impairment of ATP-P2X 1 signaling in hypertension remain unclear. From studies of P2 receptor signaling in other cell types and vascular beds, we can speculate on possible explanations for this phenomenon. It is unlikely that impairment of P2X 1 receptor activation in Ang II-induced hypertensive rats reflects downregulation of P2X 1 receptors, because P2X 1 receptor protein expression is similar in preglomerular microvessels from control and hypertensive rats; however, where the protein is localized remains to be determined. 7 Chronic increases in interstitial ATP concentration could desensitize or internalize P2X 1 receptors in Ang II hypertensive rats. 9 Inflammatory mediators invoked by hypertension could uncouple important P2X 1 receptor-dependent signaling pathways, thereby separating receptor activation from vasoconstriction. Hypertension could alter the multimeric receptor complement expressed by preglomerular microvascular smooth muscle cells. Indeed, a recent study in microvascular smooth muscle cells isolated from rat preglomerular microvessels suggests the presence of heteromeric P2X 1/4 receptors that are only sensitive to very high concentrations of ␣, ␤-methylene ATP and NF279 compared with homomeric P2X 1 receptors. 19 Alteration of the multimeric receptor profile could reduce P2X 1 receptor reactivity by shifting to a less sensitive multimeric receptor isoform. Thus, the potential role and expression of heteromeric receptors of P2X 1 in preglomerular microvessels remain to be clarified.
Recent studies also indicate that localization of P2X receptors in lipid rafts is important for P2X receptor signaling. 70 Lipid rafts are plasma membrane platforms supporting a variety of receptor-mediated signaling cascades. Disruption of lipid rafts with ␤-cyclodextrin, which moves P2X 1 receptors from a lipid raft component to a non-lipid raft component, leads to attenuated ␣, ␤-methylene ATPinduced contractility of the rat tail artery, whereas the P2Y receptor response was retained, 70 highlighting that lipid raft integrity is necessary for efficient P2X 1 receptor signaling. Interestingly, ␤-cyclodextrin also attenuated myogenic responses in de-endothelialized skeletal muscle arterioles. 71 Loss of lipid raft integrity might occur in hypertension or in inflammatory states. 70, 72 Although not studied in the renal vasculature, it is possible that localization of P2X 1 receptors in lipid rafts may be altered by immune factors leading to receptor dysfunction and impaired vascular smooth muscle cell contractility.
Conclusions
Evidence strongly supports the notion that extracellular ATP is an autocrine/paracrine factor that plays important roles in regulating renal hemodynamics, microvascular reactivity, autoregulation, and tubular transport. ATP-P2X 1 receptor signaling is important in renal autoregulation. Renal autoregulation and afferent arteriolar P2X 1 receptor reactivity are compromised in Ang II-induced hypertension. Reduction or loss of autoregulatory efficiency in hypertension can promote hypertensive renal injury. Although inflammatory processes make important contributions to renal injury by blunting microvascular reactivity to P2X 1 receptor activation and, thus, autoregulatory impairment, it is unclear how hypertension impairs P2X 1 receptor activation. It is, therefore, important to understand the ontogeny of renal autoregulation and its control. It would also be very interesting to examine whether impaired P2X 1 receptor signaling in P2X 1 receptor-deficient mice could cause severe renal damage under hypertension. Better understanding of the mechanisms responsible for the deterioration of afferent arteriolar function in hypertension might reveal efficient therapeutic interventions for the prevention of renal injury.
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